Aimee J. Lenar - 25 Feb 2026 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role
EVP, US Pharma
Signature
/s/ Brianna M. Dorsi attorney-in-fact
Issuer symbol
BHC
Transactions as of
25 Feb 2026
Net transactions value
-$106,171
Form type
4
Filing time
27 Feb 2026, 17:21:50 UTC
Previous filing
18 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lenar Aimee J. EVP, US Pharma 400 SOMERSET CORPORATE BLVD., BRIDGEWATER /s/ Brianna M. Dorsi attorney-in-fact 27 Feb 2026 0002029927

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Award $0 +157,139 +60% $0.000000 417,913 25 Feb 2026 Direct F1
transaction BHC Common Shares, No Par Value Tax liability $106,171 -17,578 -4.2% $6.04 400,335 26 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
F2 This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.